View in EDS HTML Full Text PDF Full Text

Dolutegravir and Risk of Neuropsychiatric Adverse Events: A Pharmacogenetic Study.

Saved in:
Bibliographic Details
Title: Dolutegravir and Risk of Neuropsychiatric Adverse Events: A Pharmacogenetic Study.
Authors: De Greef J; Louvain Centre for Toxicology and Applied Pharmacology, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain (UCLouvain), Brussels, Belgium.; Service de Médecine Interne et Maladies Infectieuses, HIV/AIDS Reference Center, Cliniques universitaires Saint-Luc, Brussels, Belgium., Yombi JC; Service de Médecine Interne et Maladies Infectieuses, HIV/AIDS Reference Center, Cliniques universitaires Saint-Luc, Brussels, Belgium., Vincent A; Service de Médecine Interne et Maladies Infectieuses, HIV/AIDS Reference Center, Cliniques universitaires Saint-Luc, Brussels, Belgium., Vandercam B; Service de Médecine Interne et Maladies Infectieuses, HIV/AIDS Reference Center, Cliniques universitaires Saint-Luc, Brussels, Belgium., de Timary P; Service de Psychiatrie Adulte, Institut de Psychiatrie Intégrée, Cliniques universitaires Saint-Luc, Brussels, Belgium.; Institute of Neuroscience, Université Catholique de Louvain (UCLouvain), Brussels, Belgium., Boland L; Department of Clinical Chemistry, Cliniques universitaires Saint-Luc, Brussels, Belgium., Philippeau M; Molecular Biology Laboratory, Center for Human Genetics, Cliniques universitaires Saint-Luc, Brussels, Belgium., Panin N; Louvain Centre for Toxicology and Applied Pharmacology, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain (UCLouvain), Brussels, Belgium., Elens L; Louvain Centre for Toxicology and Applied Pharmacology, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain (UCLouvain), Brussels, Belgium.; Integrated PharmacoMetrics, PharmacoGenomics and PharmacoKinetics, Louvain Drug Research Institute, Université Catholique de Louvain  (UCLouvain), Brussels, Belgium., Haufroid V; Louvain Centre for Toxicology and Applied Pharmacology, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain (UCLouvain), Brussels, Belgium.; Department of Clinical Chemistry, Cliniques universitaires Saint-Luc, Brussels, Belgium., Belkhir L; Louvain Centre for Toxicology and Applied Pharmacology, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain (UCLouvain), Brussels, Belgium.; Service de Médecine Interne et Maladies Infectieuses, HIV/AIDS Reference Center, Cliniques universitaires Saint-Luc, Brussels, Belgium.
Source: The Journal of infectious diseases [J Infect Dis] 2025 Jul 11; Vol. 231 (6), pp. 1425-1429.
Publication Type: Journal Article
Journal Info: Publisher: Oxford University Press Country of Publication: United States NLM ID: 0413675 Publication Model: Print Cited Medium: Internet ISSN: 1537-6613 (Electronic) Linking ISSN: 00221899 NLM ISO Abbreviation: J Infect Dis Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40036182
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Dolutegravir and Risk of Neuropsychiatric Adverse Events: A Pharmacogenetic Study.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22De+Greef+J%22">De Greef J</searchLink>; Louvain Centre for Toxicology and Applied Pharmacology, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain (UCLouvain), Brussels, Belgium.; Service de Médecine Interne et Maladies Infectieuses, HIV/AIDS Reference Center, Cliniques universitaires Saint-Luc, Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Yombi+JC%22">Yombi JC</searchLink>; Service de Médecine Interne et Maladies Infectieuses, HIV/AIDS Reference Center, Cliniques universitaires Saint-Luc, Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Vincent+A%22">Vincent A</searchLink>; Service de Médecine Interne et Maladies Infectieuses, HIV/AIDS Reference Center, Cliniques universitaires Saint-Luc, Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Vandercam+B%22">Vandercam B</searchLink>; Service de Médecine Interne et Maladies Infectieuses, HIV/AIDS Reference Center, Cliniques universitaires Saint-Luc, Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22de+Timary+P%22">de Timary P</searchLink>; Service de Psychiatrie Adulte, Institut de Psychiatrie Intégrée, Cliniques universitaires Saint-Luc, Brussels, Belgium.; Institute of Neuroscience, Université Catholique de Louvain (UCLouvain), Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Boland+L%22">Boland L</searchLink>; Department of Clinical Chemistry, Cliniques universitaires Saint-Luc, Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Philippeau+M%22">Philippeau M</searchLink>; Molecular Biology Laboratory, Center for Human Genetics, Cliniques universitaires Saint-Luc, Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Panin+N%22">Panin N</searchLink>; Louvain Centre for Toxicology and Applied Pharmacology, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain (UCLouvain), Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Elens+L%22">Elens L</searchLink>; Louvain Centre for Toxicology and Applied Pharmacology, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain (UCLouvain), Brussels, Belgium.; Integrated PharmacoMetrics, PharmacoGenomics and PharmacoKinetics, Louvain Drug Research Institute, Université Catholique de Louvain  (UCLouvain), Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Haufroid+V%22">Haufroid V</searchLink>; Louvain Centre for Toxicology and Applied Pharmacology, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain (UCLouvain), Brussels, Belgium.; Department of Clinical Chemistry, Cliniques universitaires Saint-Luc, Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Belkhir+L%22">Belkhir L</searchLink>; Louvain Centre for Toxicology and Applied Pharmacology, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain (UCLouvain), Brussels, Belgium.; Service de Médecine Interne et Maladies Infectieuses, HIV/AIDS Reference Center, Cliniques universitaires Saint-Luc, Brussels, Belgium.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220413675%22">The Journal of infectious diseases</searchLink> [J Infect Dis] 2025 Jul 11; Vol. 231 (6), pp. 1425-1429.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0413675 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1537-6613 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200221899%22">00221899 </searchLink><i>NLM ISO Abbreviation: </i>J Infect Dis <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40036182
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1093/infdis/jiaf098
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1425
    Titles:
      – TitleFull: Dolutegravir and Risk of Neuropsychiatric Adverse Events: A Pharmacogenetic Study.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: De Greef J
      – PersonEntity:
          Name:
            NameFull: Yombi JC
      – PersonEntity:
          Name:
            NameFull: Vincent A
      – PersonEntity:
          Name:
            NameFull: Vandercam B
      – PersonEntity:
          Name:
            NameFull: de Timary P
      – PersonEntity:
          Name:
            NameFull: Boland L
      – PersonEntity:
          Name:
            NameFull: Philippeau M
      – PersonEntity:
          Name:
            NameFull: Panin N
      – PersonEntity:
          Name:
            NameFull: Elens L
      – PersonEntity:
          Name:
            NameFull: Haufroid V
      – PersonEntity:
          Name:
            NameFull: Belkhir L
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 11
              M: 07
              Text: 2025 Jul 11
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1537-6613
          Numbering:
            – Type: volume
              Value: 231
            – Type: issue
              Value: 6
          Titles:
            – TitleFull: The Journal of infectious diseases
              Type: main
ResultId 1